Physician profile
Shawn Lee
NPI 1629364427
$1,818.35
in general payments reported to CMS, 2019-2025
27 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $94.75 · 2021: $92.43 · 2022: $368 · 2023: $484 · 2024: $218 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $199.74 | 2022-2023 | Ova1 |
| Sumitomo Pharma America, INC. | $198.67 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $180.40 | 2019-2023 | |
| Pfizer INC. | $122.96 | 2022-2024 | |
| Evofem Biosciences, INC. | $115.21 | 2021-2023 | Phexxi |
| Coopersurgical, INC. | $100.43 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Gauss Surgical INC. | $97.91 | 2019 | |
| Organon LLC | $87.52 | 2022-2024 | Nexplanon |
| Avanos Medical | $80.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.73 | 2023-2025 | |
| Becton, Dickinson and Company | $77.65 | 2019 | |
| Astellas Pharma US INC | $63.87 | 2023-2024 | Veozah |
| Boston Scientific Corporation | $63.28 | 2025 | Solyx Sis System |
| Mayne Pharma Commercial LLC | $50.89 | 2022-2023 | |
| Millicent US INC | $46.24 | 2024-2025 | Intrarosa, Femlyv |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $45.65 | 2023-2024 | |
| Daiichi Sankyo INC. | $29.38 | 2019-2024 | Injectafer |
| Hologic Sales and Service, LLC | $26.85 | 2022 | |
| Exeltis, USA INC. | $23.64 | 2022 | |
| Duchesnay USA Incorporated | $23.43 | 2019 | |
| Exact Sciences Corporation | $22.22 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $14.52 | 2023 | Venaseal |
| Phadia US INC. | $14.30 | 2024 | Immunocap |
| Mylan Pharmaceuticals INC. | $14.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.65 | 2019 | |
| Allotrope Medical, INC | $13.53 | 2022 | |
| Merck Sharp & Dohme LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.